Nanocarrier-encapsulated SGLT-2 inhibitor (dapagliflozin) protects against diabetic cardiomyopathy by reducing myocardial fibrosis
European Cells & Materials Journal - Open and Free Access - The Official Research Journal of AOCMF, AOTrauma, European Orthopaedic Research Society (EORS), Swiss Society for Biomaterials (SSB) and Tissue & Cell Engineering Society (TCES)
Authors
- Tong Zhao (ORCID: https://orcid.org/0000-0002-2169-6268)
- Jian Kuang (ORCID: https://orcid.org/0000-0001-5166-477X)
- Chung‐Yi Li (ORCID: https://orcid.org/0000-0002-0321-8908)
- Chin-Chang Cheng
- Lian Zhu (ORCID: https://orcid.org/0000-0001-5764-354X)
- Fang Xu (ORCID: https://orcid.org/0000-0001-6936-7079)
Publication Details
- Journal
- European Cells and Materials
- Published
- 2025-04-08
- DOI
- https://doi.org/10.22203/ecm.v050a02
- Citations
- 5
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.47